183 related articles for article (PubMed ID: 27456853)
1. p53-independent structure-activity relationships of 3-ring mesogenic compounds' activity as cytotoxic effects against human non-small cell lung cancer lines.
Fukushi S; Yoshino H; Yoshizawa A; Kashiwakura I
BMC Cancer; 2016 Jul; 16():521. PubMed ID: 27456853
[TBL] [Abstract][Full Text] [Related]
2. Dithiolation indolizine exerts viability suppression effects on A549 cells via triggering intrinsic apoptotic pathways and inducing G2/M phase arrest.
Li G; Wu X; Sun P; Zhang Z; Shao E; Mao J; Cao H; Huang H
Biomed Pharmacother; 2021 Jan; 133():110961. PubMed ID: 33190035
[TBL] [Abstract][Full Text] [Related]
3. Actinomycin V Suppresses Human Non-Small-Cell Lung Carcinoma A549 Cells by Inducing G2/M Phase Arrest and Apoptosis via the p53-Dependent Pathway.
Lin SQ; Jia FJ; Zhang CY; Liu FY; Ma JH; Han Z; Xie WD; Li X
Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31601054
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
[TBL] [Abstract][Full Text] [Related]
5. New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2/M phase.
Mohammed HHH; Abd El-Hafeez AA; Abbas SH; Abdelhafez EMN; Abuo-Rahma GEA
Bioorg Med Chem; 2016 Oct; 24(19):4636-4646. PubMed ID: 27555286
[TBL] [Abstract][Full Text] [Related]
6. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
Shapiro GI; Koestner DA; Matranga CB; Rollins BJ
Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362
[TBL] [Abstract][Full Text] [Related]
7. TLC388 Induces DNA Damage and G2 Phase Cell Cycle Arrest in Human Non-Small Cell Lung Cancer Cells.
Wu KM; Chi CW; Lai JC; Chen YJ; Kou YR
Cancer Control; 2020; 27(1):1073274819897975. PubMed ID: 32281394
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest.
Kriegs M; Gurtner K; Can Y; Brammer I; Rieckmann T; Oertel R; Wysocki M; Dorniok F; Gal A; Grob TJ; Laban S; Kasten-Pisula U; Petersen C; Baumann M; Krause M; Dikomey E
Radiother Oncol; 2015 Apr; 115(1):120-7. PubMed ID: 25796091
[TBL] [Abstract][Full Text] [Related]
9. A liquid crystal-related compound induces cell cycle arrest at the G2/M phase and apoptosis in the A549 human non-small cell lung cancer cell line.
Wakasaya T; Yoshino H; Fukushi Y; Yoshizawa A; Kashiwakura I
Int J Oncol; 2013 Apr; 42(4):1205-11. PubMed ID: 23381730
[TBL] [Abstract][Full Text] [Related]
10. The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.
Wu CC; Huang KF; Yang TY; Li YL; Wen CL; Hsu SL; Chen TH
PLoS One; 2015; 10(7):e0132052. PubMed ID: 26147394
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.
Tolis C; Peters GJ; Ferreira CG; Pinedo HM; Giaccone G
Eur J Cancer; 1999 May; 35(5):796-807. PubMed ID: 10505042
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η
Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU
J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390
[TBL] [Abstract][Full Text] [Related]
13. Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells.
Tao L; Cao Y; Wei Z; Jia Q; Yu S; Zhong J; Wang A; Woodgett JR; Lu Y
Toxicol Appl Pharmacol; 2017 Dec; 337():85-94. PubMed ID: 29074359
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer.
Wang JN; Zhang ZR; Che Y; Yuan ZY; Lu ZL; Li Y; Li N; Wan J; Sun HD; Sun N; Puno PT; He J
Cancer Biol Ther; 2018 Jul; 19(7):609-621. PubMed ID: 29565730
[TBL] [Abstract][Full Text] [Related]
15. P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.
Zhang C; Zhu H; Yang X; Lou J; Zhu D; Lu W; He Q; Yang B
J Cancer Res Clin Oncol; 2010 Mar; 136(3):437-45. PubMed ID: 19727814
[TBL] [Abstract][Full Text] [Related]
16. Novel Benzyloxyphenyl Pyrimidine-5-Carbonitrile Derivatives as Potential Apoptotic Antiproliferative Agents.
Al-Mahmoudy A; Hassan A; Ibrahim T; Youssif BGM; Taher E; Tantawy M; Abdel-Aal E; Osman N
Anticancer Agents Med Chem; 2022; 22(5):978-990. PubMed ID: 34126912
[TBL] [Abstract][Full Text] [Related]
17. BPR0C261, An Analogous of Microtubule Disrupting Agent D-24851 Enhances the Radiosensitivity of Human Non-Small Cell Lung Cancer Cells via p53-Dependent and p53-Independent Pathways.
Leu JD; Lin ST; Chen CT; Chang CA; Lee YJ
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430560
[TBL] [Abstract][Full Text] [Related]
18. Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells.
Zhang L; Ruan J; Yan L; Li W; Wu Y; Tao L; Zhang F; Zheng S; Wang A; Lu Y
Molecules; 2012 Mar; 17(4):3736-50. PubMed ID: 22450683
[TBL] [Abstract][Full Text] [Related]
19. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
[TBL] [Abstract][Full Text] [Related]
20. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]